Saturday, October 3, 2026

USD/EUR Over 2% Down In The Last 21 Sessions

USD/EUR Over 2% Down In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.11% for the last 21 sessions. At 13:07 EST on Friday, 17 May, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 3.698% up from its 52-week low and 3.898% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.18%, a negative 0.12%, and a positive 0.24%, respectively.

USD/EUR's highest amplitude of average volatility was 0.28% (last week), 0.25% (last month), and 0.24% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Eur/usd price analysis: breaks above descending trend channel, the next barrier is seen above 1.0880. According to FXStreet on Wednesday, 15 May, " On the other hand, the first downside target for EUR/USD will emerge near the 100-day EMA at 1.0795. ", "The EUR/USD pair extends the rally near 1.0825 on Wednesday during the early European trading hours."
  • Eur/usd hovers near 1.0900 with an improved risk appetite. According to FXStreet on Thursday, 16 May, "The US Dollar's (USD) decline is contributing to pressure on the EUR/USD pair, which could be attributed to the improved risk appetite."
  • Eur/usd corrects as fed's hawkish gudaince improves US dollar's appeal. According to FXStreet on Friday, 17 May, "Going forward, EUR/USD is expected to extend its upside towards the psychological resistance of 1.1000."
  • Eur/usd holds above 1.0800 ahead of eurozone gdp, according to US CPI data. According to FXStreet on Wednesday, 15 May, "The EUR/USD pair trades with a bullish bias around 1.0815 during the early Asian trading hours on Wednesday. "
  • According to FXStreet on Wednesday, 15 May, "Eren Sengezer, European Session Lead Analyst at FXStreet, offers a brief technical outlook for EUR/USD and explains: "The Relative Strength Index (RSI) indicator on the daily chart stays above 50 but EUR/USD needs to flip 1.0800-1.0820 area, where the 200-day and the 100-day Simple Moving Averages (SMA) are located, into support to extend its uptrend. ", "If EUR/USD fails to clear 1.0800-1.0820 area, buyers could get discouraged. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com